Review
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2013; 19(18): 2740-2751
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2740
Table 2 Retesting panel; first, second, and third line investigations in children with asymptomatic mild hypertransaminasemia
Retesting panel1First line panel
Second and third line panels
Liver function testsEtiology tests
ALT AST CPK GGTConjugated and unconjugated bilirubin Protein electrophoresis Serum albumin Prothrombin time and partial thromboplastin time Blood cell count Hepatic ultrasonography If only AST elevation is confirmed: PEG test and electrophoresis for macro-ASTViral markers (HAV, HBV, HCV) Minor hepatotropic viruses serology (e.g., EBV, CMV) Ceruloplasmin, serum copper ANA, SMA, LKM, LC1, anti-SLA, total IgG Serum α1 antitrypsin EMA, tTgasi IgA, deamidated AGA IgA (< 2 yr), total IgAUrinary copper, molecular ATP B7 analysis HCV RNA, HBV DNA Genetic and metabolic enlarged screening2 (“non-alcoholic fatty liver disease bin”) Sweat test Fecal elastase, steatocrit Other hepatic imaging techniques (MRI, ERCP, CT, etc.) Liver biopsy3 Jejunal biopsy (after celiac disease serology)